Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 13, 2016New England Journal of MedicineOpen Access

Ipilimumab for Patients with Relapse after Allogeneic Transplantation

View Full Paper
Ask AI
Bookmark
Share

Authors

MDMatthew S. DavidsHKHaesook T. KimPBPavan Bachireddy

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Davids et al. (2016) studied this question.

synapsesocial.com/papers/69ecef1dd55980bedc8fe5b1https://doi.org/10.1056/nejmoa1601202
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Extramedullary tumors of myeloid blasts in adults as a pattern of relapse following allogeneic bone marrow transplantation1999 · 87 citations
  2. 2Reversal of in situ T-cell exhaustion during effective human antileukemia responses to donor lymphocyte infusion2013 · 97 citations
  3. 3Cytotoxic T lymphocyte antigen-4 (CTLA-4) regulates the size, reactivity, and function of a primed pool of CD4<sup>+</sup>T cells2000 · 67 citations
  4. 4Genomic loss of patient-specific HLA in acute myeloid leukemia relapse after well-matched unrelated donor HSCT2012 · 48 citations
  5. 5Comparative outcome of nonmyeloablative and myeloablative allogeneic hematopoietic cell transplantation for patients older than 50 years of age2005 · 301 citations